Isolate Data
Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
3PoBV | 3PoBV53 | U.S. | 1994 | HIV1 | B | Plasma | MMC |
Treatment History
Order | Regimen | Weeks |
1 | NRTI+IDV | 53 |
Protease Sequence
PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
M46L, I54V, V82A | L10I, I62V, L63Q, I93L | G52S, K55Q |
>3PoBV53| 1 | codons 1-99 | clone 1 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGGFVKVRQYD QVQIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF >3PoBV53| 4 | codons 1-99 | clone 4 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGGFVKVRQYD QVQIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF >3PoBV53| 5 | codons 1-99 | clone 5 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGGFVKVRQYD QVPIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF >3PoBV53| 6 | codons 1-99 | clone 6 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGGFVKVRQYD QVQIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF >3PoBV53| 7 | codons 1-99 | clone 7 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGSFVQVRQYD QVQIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF >3PoBV53| 10 | codons 1-99 | clone 10 PQITLWQRPIVTIKIGGQLKEALLDTGADDIVLEEMNLPGRWKPKLIGGIGSFVQVRQYD QVQIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF >3PoBV53| 14 | codons 1-99 | clone 14 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGSFVQVRQYD QVQIEICGHKAIGTVLVGPTSANIIGRNLLTQLGCTLNF >3PoBV53| 18 | codons 1-99 | clone 18 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGGFVKVRQYD QVQIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF >3PoBV53| 19 | codons 1-99 | clone 19 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGGFVKVRQYD QVLIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF >3PoBV53| 20 | codons 1-99 | clone 20 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGGFVIVRQYD QVLIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF >3PoBV53| codons 1-99 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKLIGGIGSFVQVRQYD QVQIEICGHKAIGTVLVGPTPANIIGRNLLTQLGCTLNF |
References
Author | Title | Citation |
Zhang, Y-M | Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its gag substrate cleavage sites. | J Virol, 1997 |
Rhee, SY | HIV-1 protease and reverse transcriptase mutations: Correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance. | J Infect Dis, 2005 |